vicadrostat (BI 690517) - Boehringer Ingelheim
Jardiance (empagliflozin) - Eli Lilly, Boehringer Ingelheim
A Study in Healthy People to Compare How 2 Different Formulations of Vicadrostat / Empagliflozin Tablets Are Taken up in the Body (clinicaltrials.gov) - Sep 30, 2026 - P1 | N=36 | Not yet recruiting | Sponsor: Boehringer Ingelheim 
New P1 trial
http://clinicaltrials.gov/ct2/show/NCT07845630
 
Sep 30, 2026
 
Prev Next